Key result
Tissue Doppler-derived lateral atrial electromechanical delay was significantly prolonged in patients with paroxysmal atrial fibrillation and independently associated with identifying PAF (OR 1.25 per 10 ms increase, p=0.023).
Why the study?
The usefulness of tissue Doppler imaging-derived atrial electromechanical delay for detecting paroxysmal atrial fibrillation remained unknown when analyzed using high-risk cardiovascular patients as controls.
Does tissue Doppler-derived atrial electromechanical delay identify patients with paroxysmal atrial fibrillation compared to high-risk and healthy controls?
Cross-Sectional (n=146)
No
Does tissue Doppler-derived atrial electromechanical delay identify patients with paroxysmal atrial fibrillation compared to high-risk and healthy controls?
Odds Ratio: 1.25 (95% CI 1.03–1.52)
p-value: p=0.023
May support atrial delay as PAF marker; leaves open prospective validation before clinical adoption.
BACKGROUND: Tissue Doppler imaging (TDI)-derived atrial electromechanical delay (AEMD) has been reported to be useful for detecting paroxysmal atrial fibrillation (PAF). However, its usefulness remains unknown when analyzed along with patients seemingly at high-risk for AF as controls. From this standpoint, we investigated whether AEMD would be of use for identifying patients with PAF. METHODS: We retrospectively analyzed TDI recordings to obtain AEMD in 63 PAF patients. Thirty-three patients with multiple cardiovascular risk factors (MRFs) but without history of AF and 50 healthy individuals served as disease and healthy controls, respectively. AEMD was defined as the time-interval between the electrocardiogram P-wave and the beginning of the spectral TDI-derived A' for the septal (septal EMD) and lateral (lateral EMD) sides of the mitral annulus. RESULTS: ). PAF patients had longer AEMD, particularly for the lateral EMD (75 ± 23 ms), compared with disease (62 ± 22 ms, P = 0.009) and healthy (54 ± 24 ms, P < 0.001) controls. Multivariate logistic regression analysis revealed that the lateral EMD (OR 1.25, 95%CI 1.03-1.52, P = 0.023), along with the left atrial volume index (OR 2.25, 95%CI 1.44-3.51, P < 0.001), was one of the significant independent associates of identifying PAF patients. CONCLUSIONS: This cross-sectional study indicates that even analyzed together with MRFs patients, AEMD remains useful for identifying patients at risk for AF. Our results need to be confirmed by a large-scale prospective study.
No takes yet. Share an insight, caveat, or question.
Akamatsu et al. (2020) conducted a cross-sectional in Paroxysmal atrial fibrillation (n=146). Tissue Doppler-derived lateral atrial electromechanical delay (AEMD) vs. Disease controls and healthy controls was evaluated on Identification of paroxysmal atrial fibrillation (lateral EMD per 10 ms increase) (OR 1.25, 95% CI 1.03-1.52, p=0.023). Tissue Doppler-derived lateral atrial electromechanical delay was significantly prolonged in patients with paroxysmal atrial fibrillation and independently associated with identifying PAF (OR 1.25 per 10 ms increase, p=0.023).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: